Stay updated on Colistimethate Sodium in Chronic Lung Infections Clinical Trial
Sign up to get notified when there's something new on the Colistimethate Sodium in Chronic Lung Infections Clinical Trial page.

Latest updates to the Colistimethate Sodium in Chronic Lung Infections Clinical Trial page
- Check7 days agoChange DetectedThe ClinicalTrials.gov page now displays the PROMIS-II study record, including its design, eligibility criteria, outcome measures, locations, and study documents, instead of a 403 error.SummaryDifference96%

- Check13 days agoChange DetectedThe ClinicalTrials.gov page continues to show a 403 Forbidden error, and its footer revision label changes from v3.7.2 to v3.8.0.SummaryDifference0.3%

- Check20 days agoChange DetectedAn NIH announcement banner was added with links to updates and FAQs about the agency’s terminology transition from “Artificial Intelligence” to “Super Intelligence.”SummaryDifference1%

- Check27 days agoChange DetectedThe site footer revision changed from v3.7.1 to v3.7.2; the study record page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check34 days agoChange DetectedThe footer’s site revision identifier changed from v3.7.0 to v3.7.1; the study record remains unavailable behind a 403 error.SummaryDifference0.2%

- Check55 days agoChange DetectedThe page now shows a 403 Forbidden error instead of the study details, indicating restricted access to the record. This affects the visibility of the study information for visitors.SummaryDifference17%

Stay in the know with updates to Colistimethate Sodium in Chronic Lung Infections Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Colistimethate Sodium in Chronic Lung Infections Clinical Trial page.